4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001400253-26-000041
Chief Financial Officer disposed of 138 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Carter Robert Ross · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-17 | Other disposition : show line 1 in the form | −138 | $3.40 | $469 | 414,663 | D |
Loading xslF345X06/ownership.xml…